Karim Fizazi
Karim Fizazi, MD, PhD
Karim Fizazi is a medical oncologist at Institut Gustave Roussy and full professor in oncology at the University of Paris Saclay in Villejuif, France. Fizazi is the president of the French Groupe d’Etude des Tumeurs Genito-Urinaires (GETUG) and head of the GU oncology group at Gustave Roussy
Disclosures: Amgen, Arvinas, Astellas, AstraZeneca, Bayer, Clovis, CureVac, Daiichi Sankyo, Janssen, MacroGenics, MSD, Novartis (Advanced Accelerator Applications), Orion, Pfizer, and Sanofi.
View content featuring Fizazi:
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.